For patients

Antiphospholipid syndrome (APS)

APS, antiphospholipid antibodies, Hughes syndrome

Are you a clinician? See the clinical version of this page.

The short versionAntiphospholipid syndrome raises the risk of blood clots and certain pregnancy problems, but with the right treatment, usually low-dose aspirin plus a blood-thinning injection, most pregnancies go well. Close teamwork between rheumatology and a high-risk pregnancy team makes the difference.

What to know

Will APS affect the pregnancy?

APS can raise the risk of miscarriage, pre-eclampsia, growth problems, and, less often, stillbirth. Treatment lowers these risks. Your live-birth chances depend a lot on your exact antibody pattern and whether you have had a blood clot before. In one large study of treated primary APS pregnancies, live births ranged from about 3 in 10 with the highest-risk pattern (all three antibodies positive) to about 8 in 10 with the lowest-risk pattern (lupus anticoagulant alone). Ask your team which pattern applies to you.

Treatment in pregnancy

Most people with obstetric APS take low-dose aspirin plus a daily blood-thinning injection (heparin). If you have had a blood clot before, you will usually be on a full anticoagulation dose.

Planning ahead

Before pregnancy your team confirms your antibody pattern and history and sets your aspirin and heparin plan. If you take warfarin, it is switched to injections.

If standard treatment is not enough

If problems continue despite aspirin and heparin, your team may add hydroxychloroquine. Adding a steroid (prednisone) to aspirin and heparin is specifically not recommended.

Monitoring in pregnancy

You will have extra checks on blood pressure and the baby's growth, with ultrasounds of blood flow to the placenta.

After birth

The weeks after birth carry a higher clot risk, so blood-thinning is usually continued for a while. Some contraceptives that contain estrogen are avoided.

The numbers, in plain terms

About 80 in 100 (lupus anticoagulant alone)

In one large study of treated primary APS pregnancies, about 80 in 100 women whose only positive test was lupus anticoagulant had a live birth. This is the lowest-risk antibody pattern.

About 30 in 100 (all three antibodies positive)

In the same study, about 30 in 100 women who tested positive for all three antibodies (triple-positive) had a live birth, even with treatment. This is the highest-risk pattern and is worth close specialist planning. These figures come from one retrospective study; your own team can tell you what applies to you.

iThis page helps you prepare a conversation with your care team. It does not replace individual medical advice. Always confirm your own plan with your rheumatology and pregnancy team.
!

When to call your team